Risk of Fractures in Older Adults Living with HIV

Jesus Daniel Aguilar Martinez*; Barron Garcia Sevigne Tania; Arontes Montes de Oca David Alejandro; Vazquez Soto Andrea Sacramento; Caldera Finol Alberto Jose

**Jesus Daniel Aguilar Martinez*, Barron Garcia Sevigne Tania, Arontes Montes de Oca David Alejandro, Vazquez Soto Andrea Sacramento and Caldera Finol Alberto Jose**

Volume3-Issue10
Dates: Received: 2022-10-12 | Accepted: 2022-10-15 | Published: 2022-10-17
Pages: 1189-1193

Abstract

Recently, the impact of Human Immunodeficiency Virus (HIV) in older patients has began to be observed, creating a field that has not being explored at its fullest by infectologists and geriatricians. The complications associated with the pathogenesis of the disease and the antiretroviral therapy have a great impact on bone disease, specifically the risk of suffering bone fractures.

The aim of this article is to make a compilation of the most recent evidence that supports the relation of the repercussions that the pathogenesis of HIV, the Highly Active Antiretroviral Therapy (HAART) medication and the social aspects has with the increased risk of bone fracture on HIV+ elder individuals.

FullText HTML FullText PDF DOI: 10.37871/jbres1577

Certificate of Publication

Copyright

How to cite this article

Aguilar Martinez JD, Sevigne Tania BG, de Oca David Alejandro AM, Andrea Sacramento VS, Alberto Jose CF. Risk of Fractures in Older Adults Living with HIV. 2022 Oct 17; 3(10): 1189-1193. doi: 10.37871/jbres1577, Article ID: JBRES1577, Available at: https://www.jelsciences.com/articles/jbres1577.pdf

Subject area(s)

Antiretrovirology

Infectious Diseases

Virology

References

Hawkins KL, Brown TT, Margolick JB, Erlandson KM. Geriatric syndromes: new frontiers in HIV and sarcopenia. AIDS. 2017 Jun 1;31 Suppl 2(Suppl 2):S137-S146. doi: 10.1097/QAD.0000000000001444. PMID: 28471944; PMCID: PMC5693390.
LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022 Oct;33(10):2049-2102. doi: 10.1007/s00198-021-05900-y. Epub 2022 Apr 28. Erratum in: Osteoporos Int. 2022 Jul 28;: PMID: 35478046; PMCID: PMC9546973.
Carlos d’ Hyver, Jesús Alberto López Guzmán, Geriatria 4ta edicion, México: Editorial El Manual Moderno, 2019.
Matuszewska A, Nowak B, Nikodem A, Jędrzejuk D, Szkudlarek D, Zduniak K, Filipiak J, Sznadruk-Bender M, Tomkalski T, Ceremuga I, Bolanowski M, Szeląg A. Effects of efavirenz and tenofovir on bone tissue in Wistar rats. Adv Clin Exp Med. 2020 Nov;29(11):1265-1275. doi: 10.17219/acem/127684. PMID: 33269812.
Antiretroviral Medications: Adverse Effects on the Kidney. Advances in Chronic Kidney Disease, 2010;17:72-82,
Pan G, Yang Z, Ballinger SW, McDonald JM. Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS. Ann N Y Acad Sci. 2006 Apr;1068:297-308. doi: 10.1196/annals.1346.057. PMID: 16831930; PMCID: PMC1634831.
Warriner AH, Burkholder GA, Overton ET. HIV-related metabolic comorbidities in the current ART era. Infect Dis Clin North Am. 2014 Sep;28(3):457-76. doi: 10.1016/j.idc.2014.05.003. PMID: 25151566.
Ciccullo A, D'Avino A, Lassandro AP, Baldin G, Borghetti A, Dusina A, Emiliozzi A, Gagliardini R, Moschese D, Belmonti S, Lombardi F, Di Giambenedetto S. Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice. Infez Med. 2018 Dec 1;26(4):336-340. PMID: 30555137.
Lee JW, Hoshino A, Inoue K, Saitou T, Uehara S, Kobayashi Y, Ueha S, Matsushima K, Yamaguchi A, Imai Y, Iimura T. The HIV co-receptor CCR5 regulates osteoclast function. Nat Commun. 2017 Dec 20;8(1):2226. doi: 10.1038/s41467-017-02368-5. PMID: 29263385; PMCID: PMC5738403.
Guan WM, Pan W, Yu W, Cao W, Lin Q, Zhang ZZ, Song XJ, Li YL, Tian JP, Xu Y, Li TS, Hsieh E. Changes in trabecular bone score and bone mineral density in Chinese HIV-Infected individuals after one year of antiretroviral therapy. J Orthop Translat. 2021 May 20;29:72-77. doi: 10.1016/j.jot.2021.04.002. PMID: 34094860; PMCID: PMC8164002.
Berner K, Strijdom H, Essop MF, Webster I, Morris L, Louw Q. Fall History and Associated Factors Among Adults Living With HIV-1 in the Cape Winelands, South Africa: An Exploratory Investigation. Open Forum Infect Dis. 2019 Oct 9;6(10):ofz401. doi: 10.1093/ofid/ofz401. PMID: 31660363; PMCID: PMC6785680.
Shiau S, Broun EC, Arpadi SM, Yin MT. Incident fractures in HIV-infected individuals: a systematic review and meta-analysis. AIDS. 2013 Jul 31;27(12):1949-57. doi: 10.1097/QAD.0b013e328361d241. PMID: 24126140; PMCID: PMC4030545.
Biver E, Calmy A, Rizzoli R. Bone health in HIV and hepatitis B or C infections. Ther Adv Musculoskelet Dis. 2017 Jan;9(1):22-34. doi: 10.1177/1759720X16671927. Epub 2016 Oct 7. PMID: 28101146; PMCID: PMC5228639.
Karasik D, Kiel DP. Genetics of the musculoskeletal system: a pleiotropic approach. J Bone Miner Res. 2008 Jun;23(6):788-802. doi: 10.1359/jbmr.080218. PMID: 18269309; PMCID: PMC3280426.
Goldspink G. Loss of muscle strength during aging studied at the gene level. Rejuvenation Res. 2007 Sep;10(3):397-405. doi: 10.1089/rej.2007.0597. PMID: 17822355.
Kruger MJ, Nell TA. Bone mineral density in people living with HIV: a narrative review of the literature. AIDS Res Ther. 2017 Jul 26;14(1):35. doi: 10.1186/s12981-017-0162-y. PMID: 28747190; PMCID: PMC5530558.
Biver E. Osteoporosis and HIV Infection. Calcif Tissue Int. 2022 May;110(5):624-640. doi: 10.1007/s00223-022-00946-4. Epub 2022 Jan 30. PMID: 35098324; PMCID: PMC9013331.
Charumbira MY, Berner K, Louw QA. Falls in people living with HIV: a scoping review. BMJ Open [Internet]. 2020;10(11):e034872.
Chisati EM, Constantinou D, Lampiao F. Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors. PLoS One. 2020 Jan 14;15(1):e0227893. doi: 10.1371/journal.pone.0227893. PMID: 31935270; PMCID: PMC6959680.
Gupta PK, Singh S, Mahto SK, Sheoran A, Garga UC, Lal AK, Jain P, Mathews SE. Prevalence and predictors of low bone mineral density in treatment-naive HIV-infected patients and its correlation with CD4 cell counts. Tzu Chi Med J. 2020 Apr 10;33(1):49-54. doi: 10.4103/tcmj.tcmj_177_19. PMID: 33505878; PMCID: PMC7821822.
LaFleur J, Bress AP, Myers J, Rosenblatt L, Crook J, Knippenberg K, Bedimo R, Tebas P, Nyman H, Esker S. Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals. Infect Dis Ther. 2018 Jun;7(2):293-308. doi: 10.1007/s40121-018-0194-1. Epub 2018 Feb 28. PMID: 29492905; PMCID: PMC5986678.
Gonciulea A, Wang R, Althoff KN, Estrella MM, Sellmeyer DE, Palella FJ, Lake JE, Kingsley LA, Brown TT. Proteinuria Is Associated With Increased Risk of Fragility Fracture in Men With or at Risk of HIV Infection. J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):e85-e91. doi: 10.1097/QAI.0000000000002039. PMID: 30939529; PMCID: PMC6565496.
Ahmad AN, Ahmad SN, Ahmad N. HIV Infection and Bone Abnormalities. Open Orthop J. 2017 Aug 21;11:777-784. doi: 10.2174/1874325001711010777. PMID: 28979590; PMCID: PMC5620402.
Boontanondha P, Nimitphong H, Musikarat S, Ragkho A, Kiertiburanakul S. Vitamin D and Calcium Supplement Attenuate Bone Loss among HIVInfected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial. Curr HIV Res. 2020;18(1):52-62. doi: 10.2174/1570162X18666200106150806. PMID: 31906840; PMCID: PMC7516332.
Noe S, Jaeger H, Wolf E. Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis : Comment on "Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis". Osteoporos Int. 2019 Aug;30(8):1705-1706. doi: 10.1007/s00198-019-05024-4. Epub 2019 May 29. PMID: 31143992.
Chisati EM, Constantinou D, Lampiao F. Management of Reduced Bone Mineral Density in HIV: Pharmacological Challenges and the Role of Exercise. Front Physiol. 2018 Aug 7;9:1074. doi: 10.3389/fphys.2018.01074. PMID: 30131721; PMCID: PMC6090029.
Brañas F, Jiménez Z, Sánchez-Conde M, Dronda F, López-Bernaldo De Quirós JC, Pérez-Elías MJ, Miralles P, Ramírez M, Moreno A, Berenguer J, Moreno S. Frailty and physical function in older HIV-infected adults. Age Ageing. 2017 May 1;46(3):522-526. doi: 10.1093/ageing/afx013. PMID: 28203694.
Erlandson KM, Zhang L, Ng DK, Althoff KN, Palella FJ Jr, Kingsley LA, Jacobson LP, Margolick JB, Lake JE, Brown TT. Risk Factors for Falls, Falls With Injury, and Falls With Fracture Among Older Men With or at Risk of HIV Infection. J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):e117-e126. doi: 10.1097/QAI.0000000000002074. PMID: 31242143; PMCID: PMC6697423.
Tassiopoulos K, Abdo M, Wu K, Koletar SL, Palella FJ Jr, Kalayjian R, Taiwo B, Erlandson KM. Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults. AIDS. 2017 Oct 23;31(16):2287-2294. doi: 10.1097/QAD.0000000000001613. PMID: 28991026; PMCID: PMC5654616.
Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006 Nov 14;20(17):2165-74. doi: 10.1097/QAD.0b013e32801022eb. PMID: 17086056.
Jacks A, Wainwright DA, Salazar L, Grimes R, York M, Strutt AM, Shahani L, Woods SP, Hasbun R. Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection. AIDS. 2015 Aug 24;29(13):1711-4. doi: 10.1097/QAD.0000000000000700. PMID: 26372282.
Akgün KM, Tate JP, Oursler KK, Crystal S, Leaf DA, Womack JA, Brown TT, Justice AC, Crothers K. Association of chronic obstructive pulmonary disease with frailty measurements in HIV-infected and uninfected Veterans. AIDS. 2016 Sep 10;30(14):2185-93. doi: 10.1097/QAD.0000000000001162. PMID: 27191979.
Álvarez Martín T, Ferrando Piqueres R, Mendoza Aguilera M, Borrego Izquierdo Y, Pascual Marmaneu O, Bellés Medall, editor. Polifarmacia y riesgo de interacciones farmacológicas en pacientes adultos con infección VIH [Internet]. Vol. 1. Revista de la OFIL; 2017.